34368-04-2

34368-04-2 structure
34368-04-2 structure
  • Name: dobutamine
  • Chemical Name: dobutamine
  • CAS Number: 34368-04-2
  • Molecular Formula: C18H23NO3
  • Molecular Weight: 301.38000
  • Catalog: API Circulatory system medication Anti-shock vasoactive drug
  • Create Date: 2018-04-02 08:00:00
  • Modify Date: 2024-01-03 10:18:28
  • Dobutamine is a synthetic catecholamine that acts on α1-AR, β1-AR, β2-AR (α-1, β-1 andβ-2 adrenoceptors). Dobutamine is a selective β1-AR agonist, relatively weak activity at α1-AR and β2-AR. Dobutamine can increase cardiac output and correct hypoperfusion[1][2][3][4].

Name dobutamine
Synonyms 4-[2-[[3-(4-Hydroxyphenyl)-1-methylpropyl]amino]ethyl]-1,2-benzenediol
DOBUTAMINE HCL
1,2-Benzenediol,4-[2-[[3-(4-hydroxyphenyl)-1-methylpropyl]amino]ethyl]-,(+-)
(+/-)-dobutamine
DOBUTAMINE HYDROCHLORIDE
4-[2-[4-(4-HYDROXYPHENYL)BUTAN-2-YLAMINO]ETHYL]BENZENE-1,2-DIOL
Description Dobutamine is a synthetic catecholamine that acts on α1-AR, β1-AR, β2-AR (α-1, β-1 andβ-2 adrenoceptors). Dobutamine is a selective β1-AR agonist, relatively weak activity at α1-AR and β2-AR. Dobutamine can increase cardiac output and correct hypoperfusion[1][2][3][4].
Related Catalog
In Vivo Dobutamine has a rapid onset of action and a short half-life [2]. Dobutamine (0.15-20 mg/kg; i.p.) results in subsequent increase in the left ventricular function and heart rate acceleration with an increasing dose in wildtype mice[3]. Dobutamine results in significant inotropic, lusitropic, and chronotropic cardiac response with a high dose in wildtype mice[3]. Low doses of Dobutamine significantly increases inotropic and lusitropic cardiac performance without chronotropic changes in the Tgαq*44 mice[3]. Dobutamine increases heart rate only after high doses, but then inotropic and lusitropic cardiac functional reserve is lost[3]. Dobutamine increases alveolar liquid clearance in ventilated rats by beta-2 receptor stimulation[4]. Animal Model: Tgαq*44 mice (heart failure models)[3] Dosage: 0.15 mg/kg, 0.5 mg/kg as a low dose, 1.5 mg/kg, 5 mg/kg, 20 mg/kg as a high dose Administration: Intraperitoneal injection Result: Induced different response in cardiac function on a low and high dose in mice with with heart failure.
References

[1]. Tuttle RR, et al. Dobutamine: development of a new catecholamine to selectively increase cardiac contractility. Circ Res. 1975 Jan;36(1):185-96.

[2]. Vallet B, et al. Dobutamine: mechanisms of action and use in acute cardiovascular pathology. Ann Cardiol Angeiol (Paris). 1991 Jun;40(6):397-402.

[3]. Tyrankiewicz U , et al. Characterization of the cardiac response to a low and high dose of dobutamine in the mouse model of dilated cardiomyopathy by MRI in vivo. J Magn Reson Imaging. 2013 Mar;37(3):669-77.

[4]. Tibayan FA, et al. Dobutamine increases alveolar liquid clearance in ventilated rats by beta-2 receptor stimulation. Am J Respir Crit Care Med. 1997 Aug;156(2 Pt 1):438-44.

Density 1.189g/cm3
Boiling Point 527.7ºC at 760mmHg
Molecular Formula C18H23NO3
Molecular Weight 301.38000
Flash Point 169.8ºC
Exact Mass 301.16800
PSA 72.72000
LogP 3.34770
Storage condition 2-8°C
Hazard Codes Xn: Harmful;
Risk Phrases 20/21/22-63
Safety Phrases 22-26-36/37/39
WGK Germany 3
HS Code 2922509090

~92%

34368-04-2 structure

34368-04-2

Literature: SUN PHARMACEUTICAL INDUSTRIES LIMITED Patent: WO2008/47382 A2, 2008 ; Location in patent: Page/Page column 22 ;

~%

34368-04-2 structure

34368-04-2

Literature: US3987200 A1, ;

~%

34368-04-2 structure

34368-04-2

Literature: WO2008/47382 A2, ; Page/Page column 21 ;
Precursor  3

DownStream  0

HS Code 2922509090
Summary 2922509090. other amino-alcohol-phenols, amino-acid-phenols and other amino-compounds with oxygen function. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:30.0%